KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Other Accumulated Expenses (2016 - 2018)

Historic Other Accumulated Expenses for NovoCure (NVCR) over the last 5 years, with Q4 2018 value amounting to $32000.0.

  • NovoCure's Other Accumulated Expenses fell 7777.78% to $32000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $32000.0, marking a year-over-year decrease of 7777.78%. This contributed to the annual value of $32000.0 for FY2018, which is 7777.78% down from last year.
  • Per NovoCure's latest filing, its Other Accumulated Expenses stood at $32000.0 for Q4 2018, which was down 7777.78% from $144000.0 recorded in Q4 2017.
  • In the past 5 years, NovoCure's Other Accumulated Expenses ranged from a high of $712000.0 in Q4 2015 and a low of $32000.0 during Q4 2018
  • Over the past 5 years, NovoCure's median Other Accumulated Expenses value was $97000.0 (recorded in 2014), while the average stood at $212200.0.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 63402.06% in 2015, then tumbled by 8932.58% in 2016.
  • Quarter analysis of 5 years shows NovoCure's Other Accumulated Expenses stood at $97000.0 in 2014, then soared by 634.02% to $712000.0 in 2015, then tumbled by 89.33% to $76000.0 in 2016, then soared by 89.47% to $144000.0 in 2017, then tumbled by 77.78% to $32000.0 in 2018.
  • Its Other Accumulated Expenses stands at $32000.0 for Q4 2018, versus $144000.0 for Q4 2017 and $76000.0 for Q4 2016.